Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 13;71(19):664-666.
doi: 10.15585/mmwr.mm7119a3.

Notes from the Field: Trends in Gabapentin Detection and Involvement in Drug Overdose Deaths - 23 States and the District of Columbia, 2019-2020

Notes from the Field: Trends in Gabapentin Detection and Involvement in Drug Overdose Deaths - 23 States and the District of Columbia, 2019-2020

Christine L Mattson et al. MMWR Morb Mortal Wkly Rep. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Figures

FIGURE
FIGURE
Quarterly trends in gabapentin detection and involvement of gabapentin and other substances in drug overdose deaths among decedents in whom gabapentin was detected, by substance involvement — 23 states and the District of Columbia, 2019–2020 Abbreviation: Q = quarter. * Substances determined to have caused death. When nonspecific terminology was used in an overdose cause of death statement (e.g., multidrug overdose), all drugs detected in postmortem toxicology were included as involved in the death. For example, if the cause of death was “multidrug overdose,” and toxicology results were positive for five drugs, all five were classified as involved. Twenty-three states (Alaska, Connecticut, Delaware, Georgia, Illinois, Maine, Massachusetts, Minnesota, Missouri, Nevada, New Hampshire, New Jersey, New Mexico, North Carolina, Oklahoma, Pennsylvania, Rhode Island, Tennessee, Utah, Vermont, Virginia, Washington, and West Virginia) and the District of Columbia.

References

    1. Wiffen PJ, Derry S, Bell RF, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2017;6:CD007938. 10.1002/14651858.CD007938.pub4 - DOI - PMC - PubMed
    1. Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study. PLoS Med 2017;14:e1002396. 10.1371/journal.pmed.1002396 - DOI - PMC - PubMed
    1. Reynolds K, Kaufman R, Korenoski A, Fennimore L, Shulman J, Lynch M. Trends in gabapentin and baclofen exposures reported to U.S. poison centers. Clin Toxicol (Phila) 2020;58:763–72. 10.1080/15563650.2019.1687902 - DOI - PubMed
    1. Finlayson G, Chavarria M, Chang S, et al. Gabapentin in mixed drug fatalities: does this frequent analyte deserve more attention? Acad Forensic Pathol 2017;7:99–111. 10.23907/2017.012 - DOI - PMC - PubMed
    1. Davis GG, Cadwallader AB, Fligner CL, et al. Position paper: recommendations for the investigation, diagnosis, and certification of deaths related to opioids and other drugs. Am J Forensic Med Pathol 2020;41:152–9. 10.1097/PAF.0000000000000550 - DOI - PubMed